[
    [
        {
            "time": "",
            "original_text": "无一下跌：单日暴涨500亿 牛市旗手“满血复活”",
            "features": {
                "keywords": [
                    "单日暴涨",
                    "牛市",
                    "满血复活"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "证券"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "无一下跌：单日暴涨500亿 牛市旗手“满血复活”",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 7,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "保荐机构列第四大股东 慧辰资讯科创板IPO定增并购蒙利益输送疑云",
            "features": {
                "keywords": [
                    "保荐机构",
                    "第四大股东",
                    "慧辰资讯",
                    "科创板",
                    "IPO",
                    "定增并购",
                    "利益输送",
                    "疑云"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "保荐机构列第四大股东 慧辰资讯科创板IPO定增并购蒙利益输送疑云",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        }
    ]
]